DND PharmaTech Inc
KOSDAQ:347850
Cash Flow Statement
Cash Flow Statement
DND PharmaTech Inc
| Jun-2025 | Sep-2025 | ||
|---|---|---|---|
| Operating Cash Flow | |||
| Net Income |
(50 895)
|
(36 583)
|
|
| Depreciation & Amortization |
8 343
|
5 582
|
|
| Stock-Based Compensation |
1 281
|
1 217
|
|
| Other Non-Cash Items |
11 900
|
9 941
|
|
| Cash Taxes Paid |
(28)
|
(22)
|
|
| Cash Interest Paid |
610
|
660
|
|
| Change in Working Capital |
(4 363)
|
(3 196)
|
|
| Cash from Operating Activities |
(35 016)
N/A
|
(24 256)
+31%
|
|
| Investing Cash Flow | |||
| Capital Expenditures |
(443)
|
(199)
|
|
| Other Items |
(200)
|
307
|
|
| Cash from Investing Activities |
(643)
N/A
|
109
N/A
|
|
| Financing Cash Flow | |||
| Net Issuance of Common Stock |
43 575
|
7 274
|
|
| Net Issuance of Debt |
(3 580)
|
16 928
|
|
| Other |
19 649
|
(64)
|
|
| Cash from Financing Activities |
59 644
N/A
|
24 138
-60%
|
|
| Change in Cash | |||
| Effect of Foreign Exchange Rates |
369
|
189
|
|
| Net Change in Cash |
24 354
N/A
|
179
-99%
|
|
| Free Cash Flow | |||
| Free Cash Flow |
(35 459)
N/A
|
(24 455)
+31%
|
|